Primary Sj?gren's Syndrome: health experiences and predictors of health quality among patients in the United States

详细信息    查看全文

• 作者：Barbara Segal (1)
  Simon J Bowman (2)
  Philip C Fox (3)
  Frederick B Vivino (4)
  Nandita Murukutla (5)
  Jeff Brodscholl (6)
  Sarika Ogale (7)
  Lachy McLean (8)
  
• 刊名：Health and Quality of Life Outcomes
• 出版年：2009
• 出版时间：December 2009
• 年：2009
• 卷：7
• 期：1
• 全文大小：905KB
• 参考文献：1. Daniels TE, Fox PC: Salivary and oral components of Sjogren's syndrome. / Rheum Dis Clin North Am 1992,18(3):572-89.
  2. Thomas E, Hay EM, Hajeer A, Silman AJ: Sjogren's syndrome: A community-based study of prevalence and impact. / Brit J Rheumatol 1998, 37:1069-6. CrossRef
  3. Sutcliffe N, Stoll T, Pyke S, Isenberg DA: Functional disability and end-organ damage in patients with systemic lupus and Sjogren's syndrome. / J Rheumatol. 1998,25(1):63-8.
  4. Tensing EK, Solovieva SA, Tervahartiala T, Nordstrom DC, Laine M, Niissalo S, Konttinen YT: Fatigue and health profile in sicca syndrome of Sjogren's and non-Sjogren's syndrome origin. / Clin Exp Rheumatol. 2001,19(3):313-16.
  5. Strombeck B, Ekdahl C, Manthorpe R, Wikstrom I, Jacobsson LT: Health-related quality of life in primary Sjogren's syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using the SF-36. / Scand J Rheumatology 2000, 29:20-. CrossRef
  6. Belenguer R, Ramos-Casals M, Brito-Zeron P, del Pino J, Sentis J, Aguilo S, Font J: Influence of clinical and immmunological parameters on the health-related quality of life of patients with primary Sjogren's syndrome. / Clin Exp Rheumatol. 2005,23(3):351-56.
  7. Champey J, Corruble E, Gottenberg JE, Buhl C, Meyer T, Caudmont C, Berge E, Pellet J, Hardy P, Mariette X: Quality of Life and Psychological Status in Patients with Primary Sjogren's Syndrome and Sicca Symptoms without Autoimmune Features. / Arth Rheumatism 2006, 55:451-57. CrossRef
  8. Bowman SJ, Booth DA, Platts RG, UK Sjogren's Interest Group: Measurement of fatigue and discomfort in primary Sjogren's syndrome using a new questionnaire tool. / Rheumatology 2004, 43:758-64. CrossRef
  9. Rostron J, Rogers S, Longman L, Kaney S, Field EA: Health-related quality of life in patients with Primary Sjogren's Syndrome and Xerostomia: a comparative study. / Gerondontology 2002, 19:53-9. CrossRef
  10. Mertzanis P, Abetz L, Rajagopalan K, Espindle D, Chalmers R, Snyder C, Caffery B, Erdington T, Simpson T, Nelson JD, Begley C: The Relative Burdern of Dry Eye in Patient's Lives: Comparisons to a U.S. Normative Sample. / Invest Opthalmol Vis Sci 2005, 46:46-0. CrossRef
  11. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH, the European Study Group on Classification Criteria for Sjogren's Syndrome: Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. / Ann Rheum Dis 2002, 61:544-. CrossRef
  12. Ware JE, Sherbourne CD: The MOS 36-item Short-form Health Survey (SF-36): Conceptual framework and item selection. / Med Care 1992, 30:473-83. CrossRef
  13. Cleeland CS, Nakamura Y, Mendoza TR, Edwards KR, Douglas J, Serlin RC: Dimensions of the impact of cancer pain in a four country sample: new information from multidimensional scaling. / Pain 1996, 67:267-73. CrossRef
  14. Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E: Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. / Journal of Pain and Symptom Management 1997, 13:63-4. CrossRef
  15. Yu EB, Shikiar R, Howard K, Kalunian KC, Petrillo J, Thompson C, Brunetta P, Laouri M: Validation of LUP-QOL: A Lupus-specific Measure of Health-Related Quality of Life. / Eular 2006.
  16. Radloff LS: The Center for Epidemiology Studies Scale for Depression: A Self-Report depression scale for research in the general population. / Appl Psychol M 1977, 3:383-01.
  17. Fox PC, Bowman SJ, Segal B, Vivino FB, Murukutla N, Choueiri K, Ogale S, McLean L: Oral Involvement in Primary Sjogren's Syndrome. / J Am Dent Assoc 2008,139(12):1592-01.
  18. Strombeck B, Theander E, Jacobsson LT: Assessment of fatigue in primary Sjogren's Syndrome: the Swedish version of the Profile of Fatigue. / Scand J Rheumatology 2005, 34:455-59. CrossRef
  19. Bowman SJ, Booth DA, Platts RG, Field A, Rostron J, UK Sj?gren's Interest Group: Validation of the Sicca Symptoms Inventory for clinical studies of Sjogren's syndrome. / J Rheumatol 2003, 30:1259-6.
  20. Wolfe F, Hawley DJ, Wilson K: The Prevalence and Meaning of Fatigue in Rheumatic disease. / J Rheumatol 1996, 23:1407-7.
  21. Keystone E, Burmester GR, Furie R, Loveless JE, Emery P, Kremer J, Tak PP, Broder MS, Yu E, Cravets M, Magrini F, Jost F: Improvement in Patient-Reported Outcomes in a Rituximab Trial in Patients with Severe Rheumatoid Arthritis Refractory to Anti-Tumor Necrosis Factor Therapy. / Arth Rheumatism 2008,59(6):785-93. CrossRef
  22. Garcia-Carrasco M, Ramos Casals M, Rosas J, Pallares L, Calvo-Alen J, Cervera R, Font J, Ingelmo M: Primary Sjogren Syndrome: clinical and Immunologic Disease Patterns in a cohort of 400 Patients. / Medicine 2002, 81:270-80. CrossRef
  23. Ramos-Casals M, Font J, Garcia-Carrasco M, Brito MP, Rosas J, Calvo-Alen J: Primary Sjogren syndrome: hematologic patterns of disease expression. / Medicine 2002, 81:281-2. CrossRef
  24. Malinow KL, Molina R, Gordon B, Selnes OA, Provost TT, Alexander EL: Neuropsychiatric Dysfunction in Primary Sjogren's Syndrome. / Annals of Internal Medicine 1985, 103:344-49.
  25. Hietaharju A, Yli-Kerttula U, Hakkinen V, Frey H: Nervous system manifestations in Sjogren's syndrome. / Acta Neurol Scand 1990,81(2):144-2. CrossRef
  26. Drosos AA, Andonopoulos AP, Lagos G, Angelopoulos NV, Moutsopoulos HM: Neuropsychiatric abnormalities in primary Sjogren's syndrome. / Clin Exp Rheumatol 1989,7(2):207-09.
  27. Mauch E, Volk C, Kratzsch G, Krapf H, Kornhuber HH, Laufen H, Hummel KJ: Neurological and neuropsychiatric dysfunction in primary Sjogren's syndrome. / Acta Neurol Scand 1994, 89:31-5. CrossRef
  28. Valtysdottir ST, Gudbjornsson B, Lindqvist U, Hallgren R, Hetta J: Anxiety and depression in patients with primary Sjogren's syndrome. / J Rheumatol 2000, 27:165-.
  29. Valtysdottir ST, Gudbjornsson B, Hallgren R, Hetta J: Psychological well-being in patients with primary Sjogren's syndrome. / Clin Exp Rheumatol 2000,18(5):597-00.
  30. Spezialetti R, Bluestein HG, Peter JB, Alexander EL: Neuropsychiatric disease in Sjogren's syndroem: anti-ribosomal P and anti-neuronal antibodies. / Am J Medicine 1993, 95:153-. CrossRef
  31. Bjerrum K, Prause JU: Primary Sjogren's syndrome: a subjective description of the disease. / Clin Exp Rheumatol 1990,8(3):283-88.
  32. Andonopoulos AP, Lagos G, Drosos AA, Moutsopoulos HM: The spectrum of neurological involvement in Sjogren's syndrome. / Brit J Rheumatol 1990, 29:21-. CrossRef
  33. Manthorpe R, Manthorpe T, Sjoberg S: Magnetic resonance imaging of the brain in patietns with primary Sjogren's syndrome. / Scand J Rheumatology 1992, 21:148-. CrossRef
  34. Binder A, Snaith ML, Isenberg D: Sjogren's syndrome: A study of it's neurological complications. / Brit J Rheumatol 1988, 27:275-. CrossRef
  35. Reid LM, MacLullich AM: Subjective Memory Complaints and Cognitive Impairment in Older People. / Dementia and Geriatric Disorders 2006, 22:471-85. CrossRef
  36. Harboe E, Tjensvoll AB, Maroni S, Goransson LG, Greve OJ, Beyer MK, Herigstad A, Kvaloy JT, Omdal R: Neuropsychiatric syndromes in patietns with Systemic Lupus Erythematousus and primary Sjogren's Syndrome-A comparative population-based study. / Ann Rheum Dis 2008, / in press.
  37. Utset TO, Fink J, Doninger NA: Prevalence of Neurocognitive Dysfunction and Other Clinical Manifestations in Disabled Patients with Systemic Lupus Erythematosus. / J Rheumatol 2006, 33:531-38.
  
• 作者单位：Barbara Segal (1)
  Simon J Bowman (2)
  Philip C Fox (3)
  Frederick B Vivino (4)
  Nandita Murukutla (5)
  Jeff Brodscholl (6)
  Sarika Ogale (7)
  Lachy McLean (8)
  
  1. Associate Professor, Division of Rheumatic and Autoimmune Diseases, Department of Medicine, University of Minnesota, USA
  2. Consultant Rheumatologist, University Hospital Birmingham, UK
  3. Visiting Scientist, Department of Oral Medicine, Carolinas Medical Center, Charlotte, USA
  4. Clinical Associate Professor, Penn Presbyterian Medical Center, USA
  5. Research Manager,Health Care and Policy Research, Harris Interactive, USA
  6. Research Methodologist, Harris Interactive, USA
  7. Health Economist, Genentech, USA
  8. Genentech, USA
  

文摘

Objective To assess the health related quality of life of patients with primary Sj?gren's Syndrome (PSS) in a large US sample. Methods Questionnaires were mailed to 547 patients with a confirmed diagnosis of PSS (PhysR-PSS) and all active members of the Sj?gren's Syndrome Foundation USA (SSF-PSS), half of whom identified a friend without PSS to also complete the survey. Results 277 PhysR-PSS patients were compared to 606 controls. The mean age was 62 years in the PhysR-PSS group and 61 years in the control group. 90% in both groups were women. Time from first symptom to diagnosis of PSS was a mean of 7 years. Sicca related morbidity, fatigue severity, depression and pain (assessed by validated questionnaires, PROFAD-SSI, FACIT-F, CES-D, BPI) were significantly greater, and all eight SF-36 domains were significantly diminished, in patients compared to controls. Somatic fatigue was the dominant predictor of physical function and of general health. Depression was the dominant predictor of emotional well being. Health care utilization was higher in patients than controls, including out of pocket dental expenses (mean: PhysR-PSS = $1473.3, controls = $503.6), dental visits (mean: PhysR-PSS = 4.0, controls = 2.3), current treatments (mean: PhysR-PSS = 6.6, controls = 2.5), and hospitalizations (53% PhysR-PSS, vs. 40% controls). Conclusion Diminished health quality and excess health costs are prevalent among PSS patients. Health experiences and functional impact of PSS is similar among US and European patients. Delayed diagnosis, sicca related morbidity, fatigue, pain and depression are substantial suggesting unmet health needs and the importance of earlier recognition of PSS.